Net Worth Advisory Group’s Quest Diagnostics DGX Stock Holding History

Net Worth Advisory Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02M	Sell	4,833 -190	-4%	-$37.3K	0.26%	78
2026 Q1	$984K	Sell	5,023 -32	-0.6%	-$6.22K	0.2%	97
2025 Q4	$877K	Buy	5,055 +798	+19%	+$145K	0.18%	106
2025 Q3	$811K	Sell	4,257 -2,748	-39%	-$488K	0.23%	87
2025 Q2	$1.26M	Buy	7,005 +512	+8%	+$88.9K	0.28%	76
2025 Q1	$1.1M	Sell	6,493 -2	-0%	-$329	0.35%	42
2024 Q4	$980K	Buy	6,495 +62	+1%	+$9.64K	0.3%	56
2024 Q3	$999K	Buy	+6,433	New	+$961K	0.3%	54

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Net Worth Advisory Group's DGX Position: Q2 2026 in Review

Net Worth Advisory Group reduced its Quest Diagnostics (DGX) stake by 3.8% in Q2 2026, selling an estimated $37.3K and leaving 4,833 shares worth $1.02M. The position accounts for 0.26% of the portfolio, ranked #78.

Net Worth Advisory Group first reported a position in DGX in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.26M in Q2 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Net Worth Advisory Group held 4,833 shares of Quest Diagnostics worth $1.02M as of Q2 2026.
Net Worth Advisory Group sold 190 Quest Diagnostics shares in Q2 2026, an estimated $37.3K.
Quest Diagnostics made up 0.26% of Net Worth Advisory Group's portfolio in Q2 2026, its #78 holding.
Net Worth Advisory Group first reported a position in Quest Diagnostics in Q3 2024 and has held it in 8 quarters since.
Net Worth Advisory Group's Quest Diagnostics position peaked at $1.26M in Q2 2025.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.